ARCHIVES

Hearing Scheduled To Investigate ImClone’s C225 Development, Stock Trading

This article is from The Cancer Letter archive.

Vol. 28 No. 23 | June 7, 2002

Download PDF Visit The Full Archive

Related Articles

Nixon Resignation Won’t Hurt Cancer Program, Might Lead To More Money; Weinberger Stays

August 16, 1974

IARC Says Evidence Supports Mammography Screening For 50-69, Limited Evidence For 40-49

March 22, 2002

NCAB Grants Three MERIT Awards; Rimer To Leave NCI For Post At UNC

June 21, 2002

New Control Grant Guidelines Include Community Resources Development

August 22, 1975

In Brief: Krakoff To Head New M.D. Anderson Division, Two Other Appointments Made In Reorganization There

July 22, 1983

July issue of Business & Regulatory report (8 additional pages) included.

July 30, 2004